The Recall Desk
ModerateFDA (Devices)·Z-2434-2019·Announced 2019-09-11

Helena Laboratories Recalls Titan Gel Serum Protein Control Kits

Helena Laboratories is recalling 65 kits of Titan Gel Serum Protein Control due to customer complaints about a narrow assay range.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any injuries, illnesses, or hospitalizations. The hazard is limited to performance issues (narrow assay range) without reported harm, fitting the criteria for a moderate severity score.

Plain-English summary

Helena Laboratories, Inc. is recalling 65 kits of Titan Gel Serum Protein Control (Catalog No. 5136). The recall is being conducted due to customer-experienced complaints regarding a narrow assay range compared to prior lots, which resulted in users being out of the assay range.

The affected product is identified by Lot Code 1-16-5136 and has an expiration date of 3-17. The product was distributed domestically in Florida, Illinois, Minnesota, Montana, New York, Ohio, Tennessee, Texas, Virginia, and Wisconsin, as well as internationally in Australia, Canada, Jordan, and South Korea.

Users should stop using the affected product and contact Helena Laboratories for further instructions.

The recalled product

Product
Titan Gel Serum Protein Control: SPE Control Cat. No 5136 1 x 2.0 mL
Affected units
65

Distribution

Distributed in 10 states:

Same manufacturer · Helena Laboratories, Inc.

See all →